King F 4th

Department of Psychiatry, Massachusetts General Hospital, Boston.

9 papers

ArticlePsychedelics

From Schedule I to the Clinic-Insights Into Psychedelic Drug Development From GHB.

Barnett BS, King F 4th

Europe PMC2026
ArticlePsychedelics

Psychedelic treatments and general hospital psychiatry: Emerging themes and future directions.

Hales S, King F 4th, Huffman J

Europe PMC2026
ArticleKetamine

Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience.

Cohen R, Bastos J, Cunha C +5

Europe PMC2026
ArticleLSD

Who Keeps Using Lysergic Acid Diethylamide? Correlates of Past-Year Use in People Who Initiated Use at least Five Years Ago.

Barnett BS, Anand A, Weleff J +2

Europe PMC2026
ArticlePsychedelics

Psychiatric Residents' Perspectives on Psychedelics and Psychedelic Assisted Therapy.

Barnett BS, Arakelian M, Weleff J +4

Europe PMC2025
ArticlePsilocybin

Psychedelic-assisted therapy: An overview for the internist.

Barnett BS, Mauney EE, King F 4th

Europe PMC2025
ArticlePsilocybin

Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.

Mauney E, King F 4th, Burton-Murray H +1

Europe PMC2025
ArticlePsilocybin

Is Poorly Assisted Psilocybin Treatment an Increasing Risk?

Schenberg EE, King F 4th, da Fonseca JE +1

Europe PMC2024
ArticlePsychedelics

Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.

King F 4th, Hammond R

Europe PMC2021